Browse AMR Mutations
Explore antimicrobial resistance mutations from the literature
Explore antimicrobial resistance mutations from the literature
Overview
Prevalence of extensively drug-resistant tuberculosis in a Chinese multidrug-resistant TB cohort after redefinition.
Should moxifloxacin be used for the treatment of extensively drug-resistant tuberculosis? An answer from a murine model.
Mutation in gyrB was associated with increased MICs for fluoroquinolones.
Beijing genotype of Mycobacterium tuberculosis is significantly associated with high-level fluoroquinolone resistance in Vietnam.
Several mutations in gyrB were identified and associated with fluoroquinolone resistance.
Association of mutation patterns in gyrA/B genes and ofloxacin resistance levels in Mycobacterium tuberculosis isolates from East China in 2009.
Some gyrB mutations were found in OFX-susceptible strains, suggesting they may not be solely responsible for resistance.
New insights into fluoroquinolone resistance in Mycobacterium tuberculosis: functional genetic analysis of gyrA and gyrB mutations.
Mutations in gyrB were analyzed for their impact on fluoroquinolone resistance.
Molecular diagnosis of fluoroquinolone resistance in Mycobacterium tuberculosis.
Mutations in gyrB are associated with fluoroquinolone resistance.
Molecular Analysis of Anti-Tuberculosis Drug Resistance of Mycobacterium tuberculosis Isolated in the Republic of Korea.
Systematic review of allelic exchange experiments aimed at identifying mutations that confer drug resistance in Mycobacterium tuberculosis.
Mutations in gyrB confer resistance to fluoroquinolones
No comments yet. Be the first to comment!
© 2026 ResLit. Data sourced from PubMed literature analysis.
Built for antimicrobial resistance research